The DOI matches its Crossref record; 516 of the 516 references it cites were found in a registry or an index.
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Open accessAbstract
The immune system is a very diverse system of the host that evolved during evolution to cope with various pathogens present in the vicinity of environmental surroundings inhabited by multicellular organisms ranging from achordates to chordates (including humans). For example, cells of immune system express various pattern recognition receptors (PRRs) that detect danger via recognizing specific pathogen-associated molecular patterns (PAMPs) and mount a specific immune response. Toll-like receptors (TLRs) are one of these PRRs expressed by various immune cells. However, they were first discovered in the Drosophila melanogaster (common fruit fly) as genes/proteins important in embryonic development and dorso-ventral body patterning/polarity. Till date, 13 different types of TLRs (TLR1-TLR13) have been discovered and described in mammals since the first discovery of TLR4 in humans in late 1997. This discovery of TLR4 in humans revolutionized the field of innate immunity and thus the immunology and host-pathogen interaction. Since then TLRs are found to be expressed on various immune cells and have been targeted for therapeutic drug development for various infectious and inflammatory diseases including cancer. Even, Single nucleotide polymorphisms (SNPs) among various TLR genes have been identified among the different human population and their association with susceptibility/resistance to certain infections and other inflammatory diseases. Thus, in the present review the current and future importance of TLRs in immunity, their pattern of expression among various immune cells along with TLR based therapeutic approach is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 516
The role of Toll-like receptors in rheumatoid arthritis
Huang, Q.-Q., & Pope, R. M. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0051-z · Cited by 246
Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens
Newman, K. C., & Riley, E. M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2057 · Cited by 246
Schulze, H. J., Cribier, B., Requena, L., Reifenberger, J., Ferrandiz, C., Garcia Diez, A., Tebbs, V., & McRae, S. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06486.x · Cited by 244
Toll‐like receptors – sentries in the B‐cell response
Bekeredjian‐Ding, I., & Jego, G. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03173.x · Cited by 243
TLR Signalling and the Function of Dendritic Cells
Hemmi, H., & Akira, S. (2005) · Chemical Immunology and Allergy · doi:10.1159/000086657 · Cited by 241
Trigeminal Nociceptors Express TLR-4 and CD14: a Mechanism for Pain due to Infection
Wadachi, R., & Hargreaves, K. M. (2006) · Journal of Dental Research · doi:10.1177/154405910608500108 · Cited by 240
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Zoglmeier, C., Bauer, H., Nörenberg, D., Wedekind, G., Bittner, P., Sandholzer, N., Rapp, M., Anz, D., Endres, S., & Bourquin, C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2672 · Cited by 238
Ma, Y., Li, J., Chiu, I., Wang, Y., Sloane, J. A., Lü, J., Kosaras, B., Sidman, R. L., Volpe, J. J., & Vartanian, T. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200606016 · Cited by 237
Platelets and Infections – Complex Interactions with Bacteria
Hamzeh-Cognasse, H., Damien, P., Chabert, A., Pozzetto, B., Cognasse, F., & Garraud, O. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00082 · Cited by 235
Vascular endothelial cell Toll-like receptor pathways in sepsis
Khakpour, S., Wilhelmsen, K., & Hellman, J. (2015) · Innate Immunity · doi:10.1177/1753425915606525 · Cited by 234
Toll-Like Receptor 3 Is a Potent Negative Regulator of Axonal Growth in Mammals
Cameron, J. S., Alexopoulou, L., Sloane, J. A., DiBernardo, A. B., Ma, Y., Kosaras, B., Flavell, R., Strittmatter, S. M., Volpe, J., Sidman, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4290-06.2007 · Cited by 233
Sepsis-induced apoptosis of the thymocytes in mice.
Wang, S. D., Huang, K. J., Lin, Y. S., & Lei, H. Y. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5014 · Cited by 232
Studies on the Anticancer and Streptolysin S‐Forming Abilities of Hemolytic Streptococci
Okamoto, H., Shoin, S., Koshimura, S., & Shimizu, R. (1967) · Japanese Journal of Microbiology · doi:10.1111/j.1348-0421.1967.tb00350.x · Cited by 232
Szajnik, M., Szczepanski, M. J., Czystowska, M., Elishaev, E., Mandapathil, M., Nowak-Markwitz, E., Spaczynski, M., & Whiteside, T. L. (2009) · Oncogene · doi:10.1038/onc.2009.289 · Cited by 226
Myeloid-Derived Suppressor Cells in Human Cancer
Nagaraj, S., & Gabrilovich, D. I. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181eb3358 · Cited by 223
Monophosphoryl Lipid A as an Adjuvant: Past Experiences and New Directions
Ulrich, J. T., & Myers, K. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_21 · Cited by 222
Target cell defense prevents the development of diabetes after viral infection
Flodström, M., Maday, A., Balakrishna, D., Cleary, M. M., Yoshimura, A., & Sarvetnick, N. (2002) · Nature Immunology · doi:10.1038/ni771 · Cited by 220
CD14 is a coreceptor of Toll-like receptors 7 and 9
Baumann, C. L., Aspalter, I. M., Sharif, O., Pichlmair, A., Blüml, S., Grebien, F., Bruckner, M., Pasierbek, P., Aumayr, K., Planyavsky, M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101111 · Cited by 220
Therapeutic potential of complement modulation
Wagner, E., & Frank, M. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3011 · Cited by 218
NKG2D ligands as therapeutic targets.
(2013) · Europe PMC (PubMed Central) · Cited by 218
Microglia and ischemic stroke: a double-edged sword
Sang, Y., Zou, X., & Zhang, Y. (2019) · Int J Immunol · doi:10.3760/cma.j.issn.1673-4394.2019.01.013 · Cited by 218
Noguchi, T., Takeda, K., Matsuzawa, A., Saegusa, K., Nakano, H., Gohda, J., Inoue, J.-I., & Ichijo, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506771200 · Cited by 217
Isnardi, I., Ng, Y.-S., Srdanovic, I., Motaghedi, R., Rudchenko, S., von Bernuth, H., Zhang, S.-Y., Puel, A., Jouanguy, E., Picard, C., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.015 · Cited by 217
Vankayalapati, R., Garg, A., Porgador, A., Griffith, D. E., Klucar, P., Safi, H., Girard, W. M., Cosman, D., Spies, T., & Barnes, P. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4611 · Cited by 215
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
Thielens, A., Vivier, E., & Romagné, F. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.001 · Cited by 214
γδ T Cells Exhibit Multifunctional and Protective Memory in Intestinal Tissues
Sheridan, B. S., Romagnoli, P. A., Pham, Q.-M., Fu, H.-H., Alonzo, F., Schubert, W.-D., Freitag, N. E., & Lefrançois, L. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.015 · Cited by 213
TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS
Zeuke, S. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00512-6 · Cited by 212
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets
Piccioli, D., Tavarini, S., Borgogni, E., Steri, V., Nuti, S., Sammicheli, C., Bardelli, M., Montagna, D., Locatelli, F., & Wack, A. (2007) · Blood · doi:10.1182/blood-2006-08-038422 · Cited by 211
HMGB1, a potent proinflammatory cytokine in sepsis
Huang, W., Tang, Y., & Li, L. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.021 · Cited by 211
Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women
Hawn, T. R., Scholes, D., Li, S. S., Wang, H., Yang, Y., Roberts, P. L., Stapleton, A. E., Janer, M., Aderem, A., Stamm, W. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005990 · Cited by 209
Toll-like receptor 4-mediated activation of murine mast cells
McCurdy, J. D., Lin, T.-J., & Marshall, J. S. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.977 · Cited by 209
Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells
Tartey, S., & Takeuchi, O. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2016.1261318 · Cited by 209
KESH, S., MENSAH, N. Y., PETERLONGO, P., JAFFE, D., HSU, K., VAN DEN BRINK, M., O'REILLY, R., PAMER, E., SATAGOPAN, J., & PAPANICOLAOU, G. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1358.012 · Cited by 208
CpG DNA and LPS induce distinct patterns of activation in human monocytes
Hartmann, G., & Krieg, A. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300880 · Cited by 208
Identification and functions of pattern-recognition receptors
Kumagai, Y., & Akira, S. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.01.058 · Cited by 207
The inflammatory role of platelets via their TLRs and Siglec receptors
Cognasse, F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00083 · Cited by 206
Development of TLR inhibitors for the treatment of autoimmune diseases
Barrat, F. J., & Coffman, R. L. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00630.x · Cited by 206
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
Engel, A. L., Holt, G. E., & Lu, H. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.5 · Cited by 205
Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
Basith, S., Manavalan, B., Yoo, T. H., Kim, S. G., & Choi, S. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0802-7 · Cited by 203
TLR‐mediated activation of NK cells and their role in bacterial/viral immune responses in mammals
Adib‐Conquy, M., Scott‐Algara, D., Cavaillon, J., & Souza‐Fonseca‐Guimaraes, F. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.99 · Cited by 203
Expression and regulation of toll-like receptors in cerebral endothelial cells
Nagyőszi, P., Wilhelm, I., Farkas, A. E., Fazakas, C., Dung, N. T. K., Haskó, J., & Krizbai, I. A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.002 · Cited by 201
Memory of Inflammation in Regulatory T Cells
van der Veeken, J., Gonzalez, A. J., Cho, H., Arvey, A., Hemmers, S., Leslie, C. S., & Rudensky, A. Y. (2016) · Cell · doi:10.1016/j.cell.2016.07.006 · Cited by 201
Venet, F., Pachot, A., Debard, A.-L., Bohé, J., Bienvenu, J., Lepape, A., & Monneret, G. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145999.42971.4b · Cited by 198
The function of γδ T cells in innate immunity
Born, W. K., Reardon, C. L., & O’Brien, R. L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.007 · Cited by 198
A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis
Thuong, N. T. T., Hawn, T. R., Thwaites, G. E., Chau, T. T. H., Lan, N. T. N., Quy, H. T., Hieu, N. T., Aderem, A., Hien, T. T., Farrar, J. J., et al. (2007) · Genes & Immunity · doi:10.1038/sj.gene.6364405 · Cited by 194
Chronic Inflammatory Diseases and Endothelial Dysfunction
Castellon, X., & Bogdanova, V. (2016) · Aging and disease · doi:10.14336/ad.2015.0803 · Cited by 191
TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen‐induced T cell activation
Cottalorda, A., Verschelde, C., Marçais, A., Tomkowiak, M., Musette, P., Uematsu, S., Akira, S., Marvel, J., & Bonnefoy‐Berard, N. (2006) · European Journal of Immunology · doi:10.1002/eji.200636181 · Cited by 190
A common human TLR1 polymorphism regulates the innate immune response to lipopeptides
Hawn, T. R., Misch, E. A., Dunstan, S. J., Thwaites, G. E., Lan, N. T. N., Quy, H. T., Chau, T. T. H., Rodrigues, S., Nachman, A., Janer, M., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737034 · Cited by 190
Gorbea, C., Makar, K. A., Pauschinger, M., Pratt, G., Bersola, J. L. F., Varela, J., David, R. M., Banks, L., Huang, C.-H., Li, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047464 · Cited by 189
Pisetsky, D. S., Erlandsson-Harris, H., & Andersson, U. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2440 · Cited by 187
Takahashi, K., Shibata, T., Akashi-Takamura, S., Kiyokawa, T., Wakabayashi, Y., Tanimura, N., Kobayashi, T., Matsumoto, F., Fukui, R., Kouro, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071132 · Cited by 186
Roquilly, A., McWilliam, H. E. G., Jacqueline, C., Tian, Z., Cinotti, R., Rimbert, M., Wakim, L., Caminschi, I., Lahoud, M. H., Belz, G. T., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.021 · Cited by 186
Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned
Boudreau, J. E., & Hsu, K. C. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.12.001 · Cited by 184
Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling
Garcia-Cattaneo, A., Gobert, F.-X., Müller, M., Toscano, F., Flores, M., Lescure, A., Del Nery, E., & Benaroch, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115091109 · Cited by 183
Awomoyi, A. A., Rallabhandi, P., Pollin, T. I., Lorenz, E., Sztein, M. B., Boukhvalova, M. S., Hemming, V. G., Blanco, J. C. G., & Vogel, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3171 · Cited by 182
A conserved Toll‐like receptor is required for Caenorhabditis elegans innate immunity
Tenor, J. L., & Aballay, A. (2008) · EMBO reports · doi:10.1038/sj.embor.7401104 · Cited by 182
Platelets: New Bricks in the Building of Neutrophil Extracellular Traps
Carestia, A., Kaufman, T., & Schattner, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00271 · Cited by 182
The Innate Immune Facet of Brain: Human Neurons Express TLR-3 and Sense Viral dsRNA
Lafon, M., Megret, F., Lafage, M., & Prehaud, C. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:29:3:185 · Cited by 181
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
Li, K., Qu, S., Chen, X., Wu, Q., & Shi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020404 · Cited by 180
Inoue, S., Suzuki-Utsunomiya, K., Okada, Y., Taira, T., Iida, Y., Miura, N., Tsuji, T., Yamagiwa, T., Morita, S., Chiba, T., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318274645f · Cited by 179
Putting the natural killer cell in its place
O’Connor, G. M., Hart, O. M., & Gardiner, C. M. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02256.x · Cited by 179
Brudecki, L., Ferguson, D. A., McCall, C. E., & El Gazzar, M. (2012) · Infection and Immunity · doi:10.1128/iai.00239-12 · Cited by 179
Impact of sepsis on CD4 T cell immunity
Cabrera-Perez, J., Condotta, S. A., Badovinac, V. P., & Griffith, T. S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5mr0114-067r · Cited by 178
Subsets, expansion and activation of myeloid-derived suppressor cells
Ribechini, E., Greifenberg, V., Sandwick, S., & Lutz, M. B. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0151-4 · Cited by 177
B cells enhance early innate immune responses during bacterial sepsis
Kelly-Scumpia, K. M., Scumpia, P. O., Weinstein, J. S., Delano, M. J., Cuenca, A. G., Nacionales, D. C., Wynn, J. L., Lee, P. Y., Kumagai, Y., Efron, P. A., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101715 · Cited by 175
Role of TLRs and DAMPs in allograft inflammation and transplant outcomes
Braza, F., Brouard, S., Chadban, S., & Goldstein, D. R. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.41 · Cited by 175
Dudek, A. Z., Yunis, C., Harrison, L. I., Kumar, S., Hawkinson, R., Cooley, S., Vasilakos, J. P., Gorski, K. S., & Miller, J. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1443 · Cited by 173
Seki, E., Tsutsui, H., Iimuro, Y., Naka, T., Son, G., Akira, S., Kishimoto, T., Nakanishi, K., & Fujimoto, J. (2005) · Hepatology · doi:10.1002/hep.20603 · Cited by 173
Panigrahi, S., Ma, Y., Hong, L., Gao, D., West, X. Z., Salomon, R. G., Byzova, T. V., & Podrez, E. A. (2013) · Circulation Research · doi:10.1161/circresaha.112.274241 · Cited by 172
Ling, G. S., Bennett, J., Woollard, K. J., Szajna, M., Fossati‐Jimack, L., Taylor, P. R., Scott, D., Franzoso, G., Cook, H. T., & Botto, M. (2014) · Nature Communications · doi:10.1038/ncomms4039 · Cited by 170
Lundberg, A. M., Drexler, S. K., Monaco, C. G., Williams, L. M., Sacre, S. M., Feldmann, M., & Foxwell, B. M. J. (2007) · Blood · doi:10.1182/blood-2007-02-072934 · Cited by 170
Roles of natural killer cells in antiviral immunity
Waggoner, S. N., Reighard, S. D., Gyurova, I. E., Cranert, S. A., Mahl, S. E., Karmele, E. P., McNally, J. P., Moran, M. T., Brooks, T. R., Yaqoob, F., et al. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.10.008 · Cited by 170
Mokuno, Y., Matsuguchi, T., Takano, M., Nishimura, H., Washizu, J., Ogawa, T., Takeuchi, O., Akira, S., Nimura, Y., & Yoshikai, Y. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.931 · Cited by 169
γδ-T cells: an unpolished sword in human anti-infection immunity
Zheng, J. H., Liu, Y., Lau, Y., & Tu, W. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.43 · Cited by 169
Kijpittayarit, S., Eid, A. J., Brown, R. A., Paya, C. V., & Razonable, R. R. (2007) · Clinical Infectious Diseases · doi:10.1086/514339 · Cited by 166
Land, W. G. (2015) · Sultan Qaboos University medical journal · doi:10.18295/2075-0528.1676 · Cited by 164
Natural Killer (NK) Cells in Antibacterial Innate Immunity: Angels or Devils?
Souza-Fonseca-Guimaraes, F., Adib-Conquy, M., & Cavaillon, J.-M. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00201 · Cited by 164
Boyton, R. J., & Altmann, D. M. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03424.x · Cited by 164
Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection
Bochud, P.-Y., Hersberger, M., Taffé, P., Bochud, M., Stein, C. M., Rodrigues, S. D., Calandra, T., Francioli, P., Telenti, A., Speck, R. F., et al. (2007) · AIDS · doi:10.1097/qad.0b013e328012b8ac · Cited by 164
Direct Costimulatory Effect of TLR3 Ligand Poly(I:C) on Human γδ T Lymphocytes
Wesch, D., Beetz, S., Oberg, H.-H., Marget, M., Krengel, K., & Kabelitz, D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1348 · Cited by 162
Toll-Like Receptor Polymorphisms, Inflammatory and Infectious Diseases, Allergies, and Cancer
Medvedev, A. E. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0140 · Cited by 161
Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk
Sun, J., Wiklund, F., Zheng, S. L., Chang, B., Balter, K., Li, L., Johansson, J.-E., Li, G., Adami, H.-O., Liu, W., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji070 · Cited by 161
Toll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy
Li, T., Ogino, S., & Qian, Z. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17699 · Cited by 160
Pathological role of Toll-like receptor signaling in cerebral malaria
Coban, C., Ishii, K. J., Uematsu, S., Arisue, N., Sato, S., Yamamoto, M., Kawai, T., Takeuchi, O., Hisaeda, H., Horii, T., et al. (2006) · International Immunology · doi:10.1093/intimm/dxl123 · Cited by 160
Liu, G., & Zhao, Y. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02651.x · Cited by 159
Agrawal, S., & Gupta, S. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9456-8 · Cited by 158
Venet, F., Pachot, A., Debard, A.-L., Bohe, J., Bienvenu, J., Lepape, A., Powell, W. S., & Monneret, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6540 · Cited by 158
Guruswamy, R., & ElAli, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030496 · Cited by 158
Regulation of B‐cell responses by Toll‐like receptors
Browne, E. P. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03587.x · Cited by 156
Innate immune functions of human γδ T cells
Beetz, S., Wesch, D., Marischen, L., Welte, S., Oberg, H., & Kabelitz, D. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.10.006 · Cited by 156
Pattern Recognition Receptors and Their Role in Innate Immunity: Focus on Microbial Protein Ligands
Areschoug, T., & Gordon, S. (2008) · KARGER eBooks · doi:10.1159/000135685 · Cited by 154
TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children
Berdeli, A., Celik, H. A., Özyürek, R., Doğrusöz, B., & Aydın, H. H. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0677-x · Cited by 154
Lauzon, N. M., Mian, F., Mackenzie, R., & Ashkar, A. A. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.08.004 · Cited by 151
Toll-Like Receptor Ligands Induce Human T Cell Activation and Death, a Model for HIV Pathogenesis
Funderburg, N., Luciano, A. A., Jiang, W., Rodriguez, B. A., Sieg, S. F., & Lederman, M. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001915 · Cited by 150
Kono, D. H., Haraldsson, M. K., Lawson, B. R., Pollard, K. M., Koh, Y. T., Du, X., Arnold, C. N., Baccalà, R., Silverman, G. J., Beutler, B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905441106 · Cited by 148
Dunzendorfer, S., Lee, H., Soldau, K., & Tobias, P. S. (2004) · The FASEB Journal · doi:10.1096/fj.03-1263fje · Cited by 148
Reversal of long-term sepsis-induced immunosuppression by dendritic cells
Benjamim, C. F., Lundy, S. K., Lukacs, N. W., Hogaboam, C. M., & Kunkel, S. L. (2004) · Blood · doi:10.1182/blood-2004-08-3251 · Cited by 147
B cell–intrinsic TLR signals amplify but are not required for humoral immunity
Meyer‐Bahlburg, A., Khim, S., & Rawlings, D. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071250 · Cited by 147
Huang, H., Ostroff, G. R., Lee, C. K., Wang, J. P., Specht, C. A., & Levitz, S. M. (2009) · Infection and Immunity · doi:10.1128/iai.00086-09 · Cited by 146
Time to abandon dogma: CD14 is expressed by non‐myeloid lineage cells
Jersmann, H. P. A. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01370.x · Cited by 146
Targeting HMGB1 in the treatment of sepsis
Wang, H., Ward, M. F., & Sama, A. E. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.863876 · Cited by 145
Toll‐like receptor 4 ligand can differentially modulate the release of cytokines by human platelets
Cognasse, F., Hamzeh‐Cognasse, H., Lafarge, S. T., Delézay, O., Pozzetto, B., McNicol, A., & Garraud, O. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.06999.x · Cited by 145
The contribution of direct TLR signaling to T cell responses
Rahman, A. H., Taylor, D. K., & Turka, L. A. (2009) · Immunologic Research · doi:10.1007/s12026-009-8113-x · Cited by 143
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets
Rondina, M. T., Schwertz, H., Harris, E. S., Kraemer, B. F., Campbell, R. A., Mackman, N., Grissom, C. K., Weyrich, A. S., & Zimmerman, G. A. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04208.x · Cited by 142
Trudler, D., Farfara, D., & Frenkel, D. (2010) · Mediators of Inflammation · doi:10.1155/2010/497987 · Cited by 142
Toll-like receptors expression and interferon-γ production by NK cells in human sepsis
Souza-Fonseca-Guimarães, F., Parlato, M., Philippart, F., Misset, B., Cavaillon, J., Adib‐Conquy, M., & the Captain study group (2012) · Critical Care · doi:10.1186/cc11838 · Cited by 142
Heuer, J. G., Zhang, T.-H., Zhao, J.-Y., Ding, C., Cramer, M. S., Justen, K. L., Vonderfecht, S., & Na, S. (2005) · Journal of Immunology · doi:10.4049/jimmunol.174.11.7141 · Cited by 142
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
Iribarren, K., Bloy, N., Buqué, A., Cremer, I., Eggermont, A. M. M., Fridman, W. H., Fucikova, J. P., Galon, J., Špíšek, R., Zitvogel, L., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1088631 · Cited by 142
Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
Jasani, B., Navabi, H., & Adams, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.071 · Cited by 141
γδ T Cells Respond Directly to Pathogen-Associated Molecular Patterns,
Hedges, J. F., Lubick, K. J., & Jutila, M. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6045 · Cited by 139
Myeloid-Derived Suppressor Cells in Bacterial Infections
Ost, M., Singh, A., Peschel, A., Mehling, R., Rieber, N. P., & Hartl, D. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00037 · Cited by 139
Modulation of γδ T cell responses by TLR ligands
Wesch, D., Peters, C., Oberg, H., Pietschmann, K., & Kabelitz, D. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0699-1 · Cited by 138
Natural killer cell education in human health and disease
Boudreau, J. E., & Hsu, K. C. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.11.003 · Cited by 137
Microglia in Infectious Diseases of the Central Nervous System
Mariani, M. M., & Kielian, T. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9170-6 · Cited by 136
Gerttula, S. M., Jin, Y., & Anderson, K. V. (1988) · Genetics · doi:10.1093/genetics/119.1.123 · Cited by 135
Navabi, H., Jasani, B., Reece, A., Clayton, A., Tabi, Z., Donninger, C., Mason, M. D., & Adams, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.10.024 · Cited by 133
THE CONTRIBUTION OF CD4+ CD25+ T-REGULATORY-CELLS TO IMMUNE SUPPRESSION IN SEPSIS
Wisnoski, N., Chung, C., Chen, Y., Huang, X., & Ayala, A. (2007) · Shock · doi:10.1097/01.shk.0000239780.33398.e4 · Cited by 132
Toll-like receptors are key players in neurodegeneration
Arroyo, D. S., Soria, J. A., Gaviglio, E. A., Rodriguez‐Galán, M. C., & Iribarren, P. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.05.006 · Cited by 132
Synthetic agonists of Toll-like receptors 7, 8 and 9
Agrawal, S., & Kandimalla, E. R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351461 · Cited by 132
Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases
Hosseini, A. M., Majidi, J., Baradaran, B., & Yousefi, M. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.082 · Cited by 132
Farrugia, M., & Baron, B. (2017) · International Journal of Inflammation · doi:10.1155/2017/8391230 · Cited by 132
Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases
Papotto, P. H., Reinhardt, A., Prinz, I., & Silva‐Santos, B. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.11.006 · Cited by 132
Signaling Organelles of the Innate Immune System
Kagan, J. C. (2012) · Cell · doi:10.1016/j.cell.2012.11.011 · Cited by 131
Fukata, M., Breglio, K. J., Chen, A., Vamadevan, A. S., Goo, T., Hsu, D. S., Conduah, D. E., Xu, R., & Abreu, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1886 · Cited by 131
Toll-like receptors in the CNS: implications for neurodegeneration and repair
van Noort, J. M., & Bsibsi, M. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17509-x · Cited by 130
Role of neutrophils in BCG immunotherapy for bladder cancer
Simons, M. P., O’Donnell, M. A., & Griffith, T. S. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.11.031 · Cited by 129
McHeyzer‐Williams, M. G. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00046-3 · Cited by 128
Early alterations of B cells in patients with septic shock
Monserrat, J., de Pablo, R., Diaz-Martín, D., Zapata, M. R., de la Hera, A., I, A. P., & Álvarez‐Mon, M. (2013) · Critical Care · doi:10.1186/cc12750 · Cited by 127
Human Lymphatic Endothelial Cells Express Multiple Functional TLRs
Pegu, A., Qin, S., Junecko, B. A. F., Nisato, R. E., Pepper, M. S., & Reinhart, T. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3399 · Cited by 126
Early natural killer cell counts in blood predict mortality in severe sepsis
Andaluz‐Ojeda, D., Iglesias, V., Bobillo, F., Almansa, R., Rico, L., Gandía, F., Loma, A. M., Nieto, C., Diego, R., Ramos, E., et al. (2011) · Critical Care · doi:10.1186/cc10501 · Cited by 123
Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
Sondak, V. K., & Sosman, J. A. (2003) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.004 · Cited by 122
Toll‐like receptors in the brain and their potential roles in neuropathology
Crack, P. J., & Bray, P. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100103 · Cited by 121
Sivori, S., Falco, M., Carlomagno, S., Romeo, E., Soldani, C., Bensussan, A., Viola, A., Moretta, L., & Moretta, A. (2010) · Blood · doi:10.1182/blood-2009-12-256586 · Cited by 118
Rodríguez-Calvo, R., Tajes, M., & Vázquez-Carrera, M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1279146 · Cited by 117
Miyagaki, T., Fujimoto, M., & Sato, S. (2015) · International Immunology · doi:10.1093/intimm/dxv026 · Cited by 116
Uronen‐Hansson, H., Allen, J. S., Osman, M., Squires, G. R., Klein, N. J., & Callard, R. E. (2004) · Immunology · doi:10.1111/j.0019-2805.2003.01803.x · Cited by 116
Human and mouse plasmacytoid dendritic cells
Hochrein, H., O’Keeffe, M. A., & Wagner, H. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00748-6 · Cited by 115
A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection
Sironi, M., Biasin, M., Cagliani, R., Forni, D., Luca, M. D., Saulle, I., Caputo, S. L., Mazzotta, F., Macı́as, J., Pineda, J. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102179 · Cited by 115
Imaizumi, T., Itaya, H., Fujita, K., Kudoh, D., Kudoh, S., Mori, K., Fujimoto, K., Matsumiya, T., Yoshida, H., & Satoh, K. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.410 · Cited by 115
Dummer, R., Hauschild, A., Becker, J. C., Grob, J., Schadendorf, D., Tebbs, V. M., Skalsky, J., Kaehler, K. C., Moosbauer, S., Clark, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1938 · Cited by 114
Talreja, J., Kabir, M. H., Filla, M. B., Stechschulte, D. J., & Dileepan, K. N. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01946.x · Cited by 113
Toll-like receptors: promising therapeutic targets for inflammatory diseases
Achek, A., Yesudhas, D., & Choi, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0806-9 · Cited by 112
Taylor, A. L., & Llewelyn, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002416 · Cited by 111
Majewska, M., & Szczepanik, M. (2006) · PubMed · Cited by 110
Toll-like receptors and B cells: functions and mechanisms
Buchta, C. M., & Bishop, G. A. (2014) · Immunologic Research · doi:10.1007/s12026-014-8523-2 · Cited by 110
Hedger, M. P. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.01.010 · Cited by 110
The MYD88-Independent Pathway Is Not Mobilized in Human Neutrophils Stimulated via TLR4
Tamassia, N., Moigne, V. L., Calzetti, F., Donini, M., Gasperini, S., Ear, T., Cloutier, A., Martínez, F. O., Fabbri, M., Locati, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7344 · Cited by 110
Human Skin Endothelial Cells Can Express All 10TLRGenes and Respond to Respective Ligands
Fitzner, N., Clauberg, S., Eßmann, F., Liebmann, J., & Kolb-Bachofen, V. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00257-07 · Cited by 110
Bekeredjian‐Ding, I., Inamura, S., Giese, T., Moll, H., Endres, S., Sing, A., Zähringer, U., & Hartmann, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2803 · Cited by 109
Brandt, J. P., & Ringstad, N. (2015) · Current Biology · doi:10.1016/j.cub.2015.07.037 · Cited by 108
Mast cells: Emerging sentinel innate immune cells with diverse role in immunity
Kumar, V., & Sharma, A. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.07.009 · Cited by 108
O’Reilly, S., & Duffy, L. (2016) · ImmunoTargets and Therapy · doi:10.2147/itt.s89795 · Cited by 108
Platelets: much more than bricks in a breached wall
Mancuso, M. E., & Santagostino, E. (2017) · British Journal of Haematology · doi:10.1111/bjh.14653 · Cited by 108
Expression of Toll‐like Receptors in Human Endometrial Epithelial Cells and Cell Lines
Young, S. L., Lyddon, T. D., Jorgenson, R. L., & Misfeldt, M. L. (2004) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2004.00189.x · Cited by 107
Application potential of toll-like receptors in cancer immunotherapy
Shi, M., Chen, X., Ye, K., Yao, Y., & Yu, L. (2016) · Medicine · doi:10.1097/md.0000000000003951 · Cited by 107
A clinical perspective of sepsis-associated delirium
Tsuruta, R., & Oda, Y. (2016) · Journal of Intensive Care · doi:10.1186/s40560-016-0145-4 · Cited by 106
Bochud, P., Magaret, A., Koelle, D. M., Aderem, A. A., & Wald, A. (2007) · The Journal of Infectious Diseases · doi:10.1086/519693 · Cited by 105
Girling, J. E., & Hedger, M. P. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100086 · Cited by 104
Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses
Frossi, B., Mion, F., Tripodo, C., Colombo, M. P., & Pucillo, C. E. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.04.001 · Cited by 103
Zipris, D., Lien, E., Nair, A., Xie, J. X., Greiner, D. L., Mordes, J. P., & Rossini, A. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.693 · Cited by 101
Ebihara, T., Azuma, M., Oshiumi, H., Kasamatsu, J., Iwabuchi, K., Matsumoto, K., Saito, H., Taniguchi, T., Matsumoto, M., & Seya, T. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091573 · Cited by 101
Jagannathan‐Bogdan, M., Hastürk, H., Liang, Y., Shin, H., Hetzel, J. T., Kantarcı, A., Rubin, D. J., McDonnell, M. E., Dyke, T. E. V., Ganley-Leal, L. M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901517 · Cited by 101
Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility
Noreen, M., & Arshad, M. (2015) · Immunologic Research · doi:10.1007/s12026-015-8640-6 · Cited by 99
Mrabet‐Dahbi, S., Metz, M., Dudeck, A., Zuberbier, T., & Maurer, M. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00878.x · Cited by 98
Ly49 receptors: innate and adaptive immune paradigms
Rahim, M. M. A., Tu, M. M., Mahmoud, A. B., Wight, A., Abou-Samra, E., Lima, P. D. A., & Makrigiannis, A. P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00145 · Cited by 97
Toll-like receptors and their role in animal reproduction
Kannaki, T. R., Shanmugam, M., & Verma, P. (2011) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2011.03.008 · Cited by 97
TLR/NCR/KIR: Which One to Use and When?
Sivori, S., Carlomagno, S., Pesce, S., Moretta, A., Vitale, M., & Marcenaro, E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00105 · Cited by 96
Toll-like receptors in transplantation: sensing and reacting to injury
Leventhal, J. S., & Schröppel, B. (2012) · Kidney International · doi:10.1038/ki.2011.498 · Cited by 95
Tantisira, K. G., Klimecki, W. T., Lazarus, R. M., Palmer, L. J., Raby, B. A., Kwiatkowski, D. J., Silverman, E. K., Vercelli, D., Martínez, F. D., & Weiss, S. T. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364096 · Cited by 95
A History of Recurrent Positive Selection at the Toll-Like Receptor 5 in Primates
Wlasiuk, G., Khan, S., Switzer, W. M., & Nachman, M. W. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp018 · Cited by 95
Toll‐Like Receptor Expression and Function in Subsets of Human γδ T Lymphocytes
Pietschmann, K., Beetz, S., Welte, S., Martens, I., Gruen, J., Oberg, H., Wesch, D., & Kabelitz, D. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02290.x · Cited by 94
Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses
Dar, A. A., Patil, R. S., & Chiplunkar, S. V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00366 · Cited by 94
Myeloid-Derived Suppressor Cells: Paradoxical Roles in Infection and Immunity
Dai, J., Gazzar, M. E., Li, G. Y., Moorman, J. P., & Yao, Z. Q. (2014) · Journal of Innate Immunity · doi:10.1159/000368233 · Cited by 93
Schott, E., Witt, H., Neumann, K., Taube, S., Oh, D., Schreier, E., Vierich, S., Puhl, G., Bergk, A., Halangk, J., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.021 · Cited by 92
Toliver-Kinsky, T. E., Cui, W., Murphey, E. D., Lin, C.-Y., & Sherwood, E. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.404 · Cited by 90
Devilder, M., Allain‐Maillet, S., Dousset, C., Bonneville, M., & Scotet, E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901571 · Cited by 89
Shin, H., Xu, F., Bagchi, A., Herrup, E. A., Prakash, A., Valentine, C., Kulkarni, H. S., Wilhelmsen, K., Warren, S. H., & Hellman, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001647 · Cited by 89
Differential production of inflammatory chemokines by murine dendritic cell subsets
Proietto, A. I., O’Keeffe, M. A., Gartlan, K. H., Wright, M. D., Shortman, K., Wu, L., & Lahoud, M. H. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.03.002 · Cited by 88
Molecular adjuvants and immunomodulators: new approaches to immunization
Johnson, A. G. (1994) · Clinical Microbiology Reviews · doi:10.1128/cmr.7.3.277 · Cited by 87
Distinct CpG oligonucleotide sequences activate human γ δ T cells via interferon-α/-β
Rothenfußer, S., Hornung, V., Krug, A., Towarowski, A., Krieg, A. Μ., Endres, S., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200112)31:12<3525::aid-immu3525>3.0.co;2-5 · Cited by 87
TLRs Mediate IFN-γ Production by Human Uterine NK Cells in Endometrium
Eriksson, M., Meadows, S. K., Basu, S., Mselle, T., Wira, C. R., & Sentman, C. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6219 · Cited by 86
Sobek, V., Birkner, N., Falk, I. J., Würch, A., Kirschning, C. J., Wagner, H., Wallich, R., Lamers, M. C., & Simon, M. M. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1212 · Cited by 86
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis
Hamann, L., Gomma, A., Schröder, N. W. J., Stamme, C., Glaeser, C., Schulz, S., Gross, M. C., Anker, S. D., Fox, K. M., & Schumann, R. R. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0643-7 · Cited by 85
Platelets as autonomous drones for hemostatic and immune surveillance
Li, J. L. Y., Zarbock, A., & Hidalgo, A. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170879 · Cited by 85
Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children
Tabel, Y., Berdeli, A., & Mir, S. (2007) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2007.00709.x · Cited by 84
Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression
Aflatoonian, R., & Fazeli, A. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2007.03.014 · Cited by 84
Chennupati, V., Worbs, T., Liu, X., Malinarich, F. H., Schmitz, S., Haas, J. D., Malissen, B., Förster, R., & Prinz, I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001652 · Cited by 84
Rosenberger, K., Derkow, K., Dembny, P., Krüger, C., Schott, E., & Lehnardt, S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0166-7 · Cited by 84
NK Cell Tolerance to TLR Agonists Mediated by Regulatory T Cells after Polymicrobial Sepsis
Souza-Fonseca-Guimarães, F., Parlato, M., Fitting, C., Cavaillon, J., & Adib‐Conquy, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103616 · Cited by 83
Association of γδ T Cells with Disease Severity and Mortality in Septic Patients
Andreu‐Ballester, J. C., Tormo-Calandín, C., García‐Ballesteros, C., Perez-Griera, J., Amigó, V., Almela-Quilis, A., del Castillo, J. R., Peñarroja-Otero, C., & Ballester, F. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00752-12 · Cited by 82
T CELLS ARE POTENT EARLY MEDIATORS OF THE HOST RESPONSE TO SEPSIS
Kasten, K. R., Tschöp, J., Adediran, S., Hildeman, D. A., & Caldwell, C. C. (2010) · Shock · doi:10.1097/shk.0b013e3181e14c2e · Cited by 82
Suzuki, K., Inoue, S., Kametani, Y., Komori, Y., Chiba, S., Sato, T., Inokuchi, S., & Ogura, S. (2016) · Shock · doi:10.1097/shk.0000000000000619 · Cited by 82
Islam, M. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3 · Cited by 81
TLR7 and TLR8 Gene Variations and Susceptibility to Hepatitis C Virus Infection
Wang, C.-H., Eng, H., Lin, K.-H., Chang, C., Hsieh, C.-A., Lin, Y.-L., & Lin, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026235 · Cited by 81
Long, E. M., Millen, B., Kubes, P., & Robbins, S. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005601 · Cited by 81
Harrison, L. I., Astry, C. L., Kumar, S., & Yunis, C. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007303766 · Cited by 80
T Cell Activation by TLRs: A Role for TLRs in the Adaptive Immune Response
MacLeod, H., & Wetzler, L. M. (2007) · Science s STKE · doi:10.1126/stke.4022007pe48 · Cited by 80
Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors
Zhao, B., Vasilakos, J. P., Tross, D., Smirnov, D., & Klinman, D. M. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-12 · Cited by 80
Chronic Inflammation and γδ T Cells
Fay, N. S., Larson, E. C., & Jameson, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00210 · Cited by 80
Mechanisms of Regulatory B cell Function in Autoimmune and Inflammatory Diseases beyond IL-10
Ray, A., & Dittel, B. N. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010012 · Cited by 79
Cited by
Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health
Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E., & Rotondo, J. C. (2023) · Cells · doi:10.3390/cells12010184 · Cited by 889
Kumar, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01722 · Cited by 684
Sameer, A. S., & Nissar, S. (2021) · BioMed Research International · doi:10.1155/2021/1157023 · Cited by 323
Huang, J.-N., Wen, B., Zhu, J.-G., Zhang, Y.-S., Gao, J.-Z., & Chen, Z.-Z. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138929 · Cited by 277
Recent clinical trends in Toll‐like receptor targeting therapeutics
Anwar, M. A., Shah, M., Kim, J., & Choi, S. (2019) · Medicinal Research Reviews · doi:10.1002/med.21553 · Cited by 275
Metadata
- Authors
- Vijay, K.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 59
- Pages
- 391-412
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2800750353
- Cited by
- 643
- References
- 516
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.